KNPCX
Price
$108.68
Change
+$0.52 (+0.48%)
Updated
Jul 25 closing price
Net Assets
1.21B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

KNPCX vs PMAQX

Header iconKNPCX vs PMAQX Comparison
Open Charts KNPCX vs PMAQXBanner chart's image
Kinetics Paradigm Adv C
Price$108.68
Change+$0.52 (+0.48%)
VolumeN/A
Net Assets1.21B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
KNPCX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KNPCX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNPCX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. KNPCX (1.21B). PMAQX pays higher dividends than KNPCX: PMAQX (0.19) vs KNPCX (0.00). KNPCX was incepted earlier than PMAQX: KNPCX (23 years) vs PMAQX (9 years). KNPCX (2.41) is less costly to investors than PMAQX (0.59). PMAQX is a more actively managed with annual turnover of: 10.50 vs. KNPCX (2.00). PMAQX has a lower initial minimum investment than KNPCX: PMAQX (0) vs KNPCX (2500). KNPCX annual gain was more profitable for investors over the last year : 23.41 vs. PMAQX (13.16). KNPCX return over 5 years is better than : 177.76 vs. PMAQX (57.67).
KNPCXPMAQXKNPCX / PMAQX
Total Expense Ratio2.390.59405%
Annual Report Gross Expense Ratio2.410.59408%
Fund Existence23 years9 years-
Gain YTD-4.1137.977-52%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B33B4%
Annual Yield % from dividends0.000.19-
Returns for 1 year23.4113.16178%
Returns for 3 years53.2749.76107%
Returns for 5 years177.7657.67308%
Returns for 10 years243.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics